Skip to main content

Table 2 Baseline Characteristics by E/A Ratio

From: Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial

 E/A ≤ 0.6E/A > 0.6–2.3E/A > 2.3P value
No. Patients2731010228 
Age- yrs. (SD)63.9 (9.0)60.3 (9.6)58.4 (9.2)< 0.001
Female (%)50 (18.3)163 (16.1)20 (8.8)0.007
Body mass index-m2 (SD)27.2 (3.9)27.8 (4.8)26.7 (4.8)0.001
Systolic blood pressure-mmHg (SD)122.3 (18.2)121.7 (17.3)115.9 (17.6)< 0.001
Heart rate-bpm (SD)71.8 (10.8)72.0 (13.5)77.4 (16.1)< 0.001
Hemoglobin-g/dL (SD)14.0 (1.60)13.7 (1.7)13.4 (1.9)0.001
Creatinine-mg/dL (SD)1.14 (0.52)1.13 (0.56)1.18 (0.32)0.001
Blood urea nitrogen-mg/dL (SD)28.7 (18.5)27.3 (19.8)33.2 (23.5)0.001
EF-% (SD)30.0 (8.2)30.1 (8.1)26.5 (8.11)< 0.001
LVESVI-cc/m2 (SD)80.0 (30.7)81.4 (29.8)92.3 (31.5)0.001
Cardiac index-L/min/m2 (SD)2.35 (0.70)2.37 (0.79)2.42 (0.88)0.8793
E/e’ (SD)12.3 (6.2)17.0 (8.4)26.9 (12.0)< 0.001
Deceleration time-ms (SD)243.5 (52.3)189.4 (50.3)135.8 (27.2)< 0.001
Normal RV function (%)224 (88.2)776 (83.6)96 (43.6)< 0.001
Sphericity index (SD)0.67 (0.08)0.68 (0.09)0.71 (0.08)< 0.001
Beta Blocker (%)236 (86.4)892 (88.3)196 (86.0)0.503
ACE inhibitor (%)219 (80.2)826 (81.8)188 (82.5)0.787
Nitrates (%)170 (62.3)567 (56.1)106 (46.3)0.002
Diuretic (%)170 (62.3)561 (55.5)167 (73.6)< 0.001
Mortality Risk at randomization index12.9 (8.5)12.1 (8.9)14.5 (9.2)0.001